<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12879-019-3909-3</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12879</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title><abbrev-journal-title abbrev-type="publisher">BMC Infect Dis</abbrev-journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12879-019-3909-3</article-id><article-id pub-id-type="manuscript">3909</article-id><article-id pub-id-type="doi">10.1186/s12879-019-3909-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-collection" specific-use="SubjectSection"><subject>Tuberculosis and other mycobacterial diseases</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="Au1"><name><surname>Zhang</surname><given-names>Zoe Xiaozhu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs1287901939093_cor1">a</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Cherng</surname><given-names>Benjamin Pei Zhi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Sng</surname><given-names>Li-Hwei</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Tan</surname><given-names>Yen Ee</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9486 5048</institution-id><institution-id institution-id-type="GRID">grid.163555.1</institution-id><institution content-type="org-division">Department of Epidemiology, Medical Board</institution><institution content-type="org-name">Singapore General Hospital</institution></institution-wrap><addr-line content-type="city">Singapore</addr-line><country country="SG">Singapore</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.240988.f</institution-id><institution content-type="org-division">Department of Clinical Epidemiology, Office of Clinical Epidemiology, Analytics, and kNowledge (OCEAN)</institution><institution content-type="org-name">Tan Tock Seng Hospital</institution></institution-wrap><addr-line content-type="city">Singapore</addr-line><country country="SG">Singapore</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9486 5048</institution-id><institution-id institution-id-type="GRID">grid.163555.1</institution-id><institution content-type="org-division">Department of Infectious Disease</institution><institution content-type="org-name">Singapore General Hospital</institution></institution-wrap><addr-line content-type="city">Singapore</addr-line><country country="SG">Singapore</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9486 5048</institution-id><institution-id institution-id-type="GRID">grid.163555.1</institution-id><institution content-type="org-division">Department of Microbiology</institution><institution content-type="org-name">Singapore General Hospital</institution></institution-wrap><addr-line content-type="city">Singapore</addr-line><country country="SG">Singapore</country></aff></contrib-group><author-notes><corresp id="IDs1287901939093_cor1"><label>a</label><email>zoe_zhang_xz@ttsh.com.sg</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>5</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>19</volume><issue seq="436">1</issue><elocation-id>436</elocation-id><history><date date-type="registration"><day>15</day><month>3</month><year>2019</year></date><date date-type="received"><day>16</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2019</year></date><date date-type="online"><day>17</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Information on non-tuberculosis mycobacterial (NTM) diseases remains limited in Singapore and other Southeast Asian countries. This study aimed to delineate epidemiological and clinical features of pulmonary NTM disease.</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">A retrospective review was performed on all NTM isolates identified in Singapore General Hospital from 2012 to 2016 using the 2007 ATS/IDSA diagnostic criteria.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">A total of 2026 NTM isolates from 852 patients were identified. <italic>M. abscessus-chelonae group</italic> (1010, 49.9%) was the most commonly isolated and implicated in pulmonary NTM disease. Pulmonary cases (352, 76%) had the highest prevalence among patients diagnosed with NTM diseases (465/852, 54.6%) with no gender difference. Male patients were older (68.5 years, <italic>P</italic> = 0.014) with a higher incidence of chronic obstructive pulmonary disease (COPD) (23.6%, <italic>P</italic> &lt; 0.001) and recurrent cough with phlegm production (51.6%, <italic>P</italic> = 0.035). In contrast, more female patients had bronchiectasis (50%, <italic>P</italic> &lt; 0.001) and haemoptysis (37.6%, <italic>P</italic> = 0.042). Age and COPD were associated with multiple NTM species isolation per patient.</p></sec><sec id="ASec4"><title>Conclusions</title><p id="Par4"><italic>M. abscessus-chelonae group</italic> was the commonest NTM species isolated in Singapore. Pulmonary NTM infection has the highest frequency with male and female patients associated with a higher incidence of COPD and bronchiectasis respectively. Age and COPD were associated with multiple NTM species isolation per patient.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Non-tuberculous mycobacteria</kwd><kwd><italic>Mycobacterium abscessus</italic></kwd><kwd>Singapore</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>15</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12879_2019_Article_3909.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Parasitology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Tropical Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Internal Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par24">Non-tuberculous mycobacteria (NTM) has been increasingly implicated in a broad range of infectious diseases worldwide [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. These environmental microbes are found primarily in water and soil. Possible route of transmission includes direct exposure to aerosolized water or soil containing NTM species [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. The interaction between host immune system and the pathogenicity of the organisms plays a key role in disease susceptibility [<xref ref-type="bibr" rid="CR6">6</xref>]. Well-defined host risk factors include advanced age, male gender, slender and older Caucasian women, immune defects, structural pulmonary diseases, alpha1-antitrypsin deficiency [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. Urban living, especially in wet area with dense population, also increases the susceptibility to NTM infections [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Other predisposing factors include low body-mass index, skeletal abnormalities and gastroesophageal reflux [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par25">Pulmonary, lymphadenitis, skin/soft tissue and dissemination are the four major clinical manifestations of NTM infections. Pulmonary NTM is the commonest clinical syndrome [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] and it is associated with significant morbidity among older adults [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Structural pulmonary diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD) bronchiectasis, and tuberculosis (TB) predispose individuals to NTM lung infections. In the United States (US), an estimation of 86,000 NTM pulmonary cases were reported in 2010 with the prevalence of 8.6 per 100, 000 [<xref ref-type="bibr" rid="CR18">18</xref>], and the number was growing by approximately 8% every year [<xref ref-type="bibr" rid="CR14">14</xref>]. In Canada, the prevalence of NTM pulmonary disease was estimated to be 9.8 per 100,000 in 2010 [<xref ref-type="bibr" rid="CR19">19</xref>]. Asians and Pacific Islanders appear to be more susceptible to NTM diseases [<xref ref-type="bibr" rid="CR14">14</xref>]. Several studies have reported the increasing number of annual NTM isolates and the significant clinical relevance [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. In Korea, the incidence of pulmonary NTM disease has doubled in 2015 compared to the number in 2009 [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Japan revealed that NTM disease has reached 14.7 cases per 100, 000 people-years [<xref ref-type="bibr" rid="CR25">25</xref>] . Pulmonary NTM disease has been described common in Taiwan, with the average incidence rate of 46.0 episodes per 100,000 hospital-based patient-years from 2010 to 2014 [<xref ref-type="bibr" rid="CR26">26</xref>]. The epidemiology of NTM pulmonary disease differs in various geographical regions. The data remains limited in Southeast Asian countries including Singapore.</p><p id="Par26">Singapore is a highly urbanized city-state with a tropical climate. It is the world’s third most densely populated country with a total population of 5.6 million. The percentage of the population aged ≥65 years is over 10% and is projected to grow to nearly 20% by 2030 [<xref ref-type="bibr" rid="CR27">27</xref>]. In addition, a large proportion of residents aged over 50 years have a history of TB as TB was prevalent in Singapore until the 1970s [<xref ref-type="bibr" rid="CR28">28</xref>]. Collectively, high population density, a wet tropical urban environment, and a large aging population with history of TB make the residents of Singapore particularly susceptible to NTM diseases. In this study, we evaluated the epidemiological and clinical characteristics of NTM diseases in Singapore, with an emphasis on pulmonary infection.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Study setting and study subjects</title><p id="Par27">Singapore General Hospital (SGH) is a 1700-bedder tertiary hospital located within the Outram Campus in Singapore with 5 other National Specialty Centres, facilitating a comprehensive range of medical services for over 1 million patients annually. SGH CTBL is one of the two centralized laboratories accredited for mycobacterial testing in Singapore and is responsible for about 80% of the country’s mycobacterial culture testing volumes. All NTM isolates identified in SGH CTBL from 1st January 2012 to 31st December 2016 were included in the study. These were speciated by a combination of methods including high-performance liquid chromatography (HPLC; Beckman Instruments, USA), INNO-LiPA Mycobacteria v2 (Innogenetics, Belgium) and/or DNA probes (AccuProbes; Gen-Probe, USA) and correlated with the colonial morphology, pigmentation and growth rate. For cases with multiple isolates of one or more species, only the first isolate of the same species was included for analysis. <italic>M. gordonae</italic>, a well-known environmental contaminant, was excluded from the analysis [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>]. Isolates were cultivated from various anatomical sites which included pulmonary source (sputum, bronchoalveolar lavage (BAL), lung biopsy, endotracheal tube aspirate (ETTA) and pleural fluid) and extrapulmonary sources such as skin and soft tissue, blood, lymph node and other sterile sites.</p></sec><sec id="Sec4"><title>Data collection</title><p id="Par28">Medical records of included cases were reviewed from the electronic medical record system by trained research coordinators with nursing or medical background. The following information were collected: 1) Patients’ demographic information, 2) medical comorbidities, 3) clinical presentations, 4) radiology findings of nodular, cavitary opacities or bronchiectasis on chest X-ray (CXR); or bronchiectasis with multiple small nodules on high resolution computed tomography (HRCT) scan, and 5) microbiology results. In addition, history of tuberculosis, body-mass index (BMI) were also recorded.</p><p id="Par29">NTM diseases were defined using the criteria proposed by 2007 American Thoracic Society and the infectious Diseases Society of America (ATS/IDSA) and were further categorized as pulmonary disease, skin/soft tissue disease, disseminated disease (blood/other sterile sites infection), lymphadenitis. NTM pulmonary disease was defined when patients had a combination of clinical, radiological, and microbiological features [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par30">Categorical variables were expressed as counts (percentage). Differences in frequencies were compared using a X<sup>2</sup> test or Fisher’s exact test. Continuous variables were expressed as median with 25-75th interquartile range (IQR), and the difference was assessed using Mann-Whitney-U test. Univariate analysis was performed to assess the association between risk factors and multi-species infection, and the results were presented as odds ratios (ORs) with 95% confidence intervals (95% CIs). All the analyses were done using STATA, version 13 for Windows.</p></sec></sec><sec id="Sec6" sec-type="results"><title>Results</title><sec id="Sec7"><title>Specimen source and NTM species distribution</title><p id="Par31">A total of 2026 NTM isolates from 852 patients were identified during the 5-year study period. The specimen types and detected species were shown in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref> respectively. Respiratory specimens were predominant (1777, 87.7%). The top four prevalent species were <italic>M. abscessus-chelonae group</italic> (1010, 49.9%), <italic>M. fortuitum</italic> group (345, 17%), <italic>M. avium</italic> complex (MAC) (309, 15.3%), and <italic>M. kansasii</italic> (233, 11.5%).<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Sources of the specimens (<italic>N</italic> = 2026)</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Specimen source</p></th><th><p>Sub-total N (%)</p></th><th><p>Total N (%)</p></th></tr></thead><tbody><tr><td colspan="3"><p>Pulmonary</p></td></tr><tr><td><p> Sputum</p></td><td><p>1519 (75)</p></td><td char="(" align="char" rowspan="5"><p>1777 (87.7%)</p></td></tr><tr><td><p> Broncho alveolar lavage</p></td><td><p>195 (9.6)</p></td></tr><tr><td><p> Lung biopsy</p></td><td><p>39 (1.9)</p></td></tr><tr><td><p> ETT aspirate</p></td><td><p>12 (0.6)</p></td></tr><tr><td><p> Pleural fluid</p></td><td><p>12 (0.6)</p></td></tr><tr><td colspan="3"><p>Extra-pulmonary</p></td></tr><tr><td><p> Skin/soft tissue</p></td><td><p>96 (4.7)</p></td><td char="(" align="char" rowspan="3"><p>249 (12.3%)</p></td></tr><tr><td><p> Blood/sterile sites</p></td><td><p>138 (6.8)</p></td></tr><tr><td><p> Lymph node</p></td><td><p>15 (0.74)</p></td></tr></tbody></table><table-wrap-foot><p>Note: the data was presented as number (%) otherwise specified</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>NTM species distribution of all the investigated isolates (<italic>N</italic> = 2026)</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Organism</p></th><th><p>No. of counts (%)</p></th></tr></thead><tbody><tr><td><p><italic>M. abscessus-chelonae group</italic></p></td><td><p>1010 (49.9)</p></td></tr><tr><td><p><italic>M. fortuitum group</italic></p></td><td><p>345 (17.0)</p></td></tr><tr><td><p><italic>M. avium complex</italic></p></td><td><p>313 (15.4)</p></td></tr><tr><td><p><italic>M. kansasii</italic></p></td><td><p>233 (11.5)</p></td></tr><tr><td><p><italic>M. haemophilum</italic></p></td><td><p>41 (2.0)</p></td></tr><tr><td><p><italic>M. scrofulaceum</italic></p></td><td><p>22 (1.1)</p></td></tr><tr><td><p><italic>M. mucogenicum</italic></p></td><td><p>16 (0.8)</p></td></tr><tr><td><p><italic>M. lentiflavum</italic></p></td><td><p>14 (0.7)</p></td></tr><tr><td><p><italic>M. triplex</italic></p></td><td><p>10 (0.5)</p></td></tr><tr><td><p><italic>M. interjectum</italic></p></td><td><p>7 (0.3)</p></td></tr><tr><td><p><italic>M. simiae</italic></p></td><td><p>7 (0.3)</p></td></tr><tr><td><p><italic>M. marinum</italic></p></td><td><p>5 (0.2)</p></td></tr><tr><td><p><italic>M. terrae complex</italic></p></td><td><p>5 (0.2)</p></td></tr><tr><td><p><italic>M. szulgai</italic></p></td><td><p>4 (0.2)</p></td></tr><tr><td><p><italic>M. genavense</italic></p></td><td><p>2 (0.1)</p></td></tr><tr><td><p><italic>M. neoaurum</italic></p></td><td><p>2 (0.1)</p></td></tr><tr><td><p><italic>M. celatum</italic></p></td><td><p>1 (0.05)</p></td></tr></tbody></table><table-wrap-foot><p>Note: the data was presented as number (%) otherwise specified</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>NTM diseases</title><p id="Par32">The study flowchart is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Due to single sputum culture or the absence of characterized radiological changes as described in ATS/IDSA guideline, 387 patients with NTM isolate(s) from respiratory specimens (45.3%) were excluded from further analysis. Among the rest 465 patients (54.6%) who fulfilled ATS/IDSA diagnostic criteria, 460 patients had NTM isolated from one source, whereas 5 other patients had NTM isolated from ≥2 sources. The detailed disease distribution was illustrated in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. Comorbidities of patients with NTM isolates from blood/other sterile sites mainly consisted of HIV/intro-venous drug abuse (11/49, 22.4%), malignancies (10/49, 20.4%), end stage renal failure (10/49, 20.4%), and ischemia heart disease /chronic heart failure (9/49, 18.4%). The species and isolates distribution of patients with NTM diseases were listed in Tables <xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>The study flowchart</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_3909_Fig1_HTML.png" id="MO1"/></p></fig><fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>The distribution of NTM diseases among the study subjects</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_3909_Fig2_HTML.png" id="MO2"/></p></fig><table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>NTM species distribution among the patients diagnosed with NTM diseases (<italic>N</italic> = 460)</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Species</p></th><th><p>Pulmonary <italic>N</italic> = 352 (%)</p></th><th><p>Skin/soft tissue <italic>N</italic> = 50 (%)</p></th><th><p>Blood/ other sterile sites <italic>N</italic> = 49 (%)</p></th><th><p>Lymph node</p><p><italic>N</italic> = 9 (%)</p></th><th><p>Total <italic>N</italic> = 460 (%)</p></th></tr></thead><tbody><tr><td><p>M. chelonae -M. abscessus group</p></td><td><p>197 (56)</p></td><td char="(" align="char"><p>25 (50)</p></td><td char="(" align="char"><p>16 (32.7)</p></td><td><p>6(66.7)</p></td><td><p>244 (53)</p></td></tr><tr><td><p><italic>M. avium</italic> complex (MAC)</p></td><td><p>99 (28.1)</p></td><td char="(" align="char"><p>4 (8)</p></td><td char="(" align="char"><p>14 (28.6)</p></td><td><p>1 (11.1)</p></td><td><p>118 (25.7)</p></td></tr><tr><td><p>M. fortuitum species group</p></td><td><p>91 (25.9)</p></td><td char="(" align="char"><p>7 (14)</p></td><td char="(" align="char"><p>15 (30.6)</p></td><td><p>0</p></td><td><p>113 (24.6)</p></td></tr><tr><td><p>M. kansasii</p></td><td><p>71 (20.2)</p></td><td/><td char="(" align="char"><p>1 (2.0)</p></td><td><p>1 (11.1)</p></td><td><p>73 (15.9)</p></td></tr><tr><td><p>M. scrofulaceum</p></td><td><p>8 (2.3)</p></td><td/><td/><td/><td><p>8 (1.7)</p></td></tr><tr><td><p>M. mucogenicum</p></td><td><p>6 (1.7)</p></td><td/><td char="(" align="char"><p>2 (4.1)</p></td><td/><td><p>8 (1.7)</p></td></tr><tr><td><p>M. lentiflavum</p></td><td><p>3 (0.9)</p></td><td/><td/><td/><td><p>3 (0.7)</p></td></tr><tr><td><p>M. szulgai</p></td><td><p>2 (0.6)</p></td><td/><td/><td/><td><p>2 (0.4)</p></td></tr><tr><td><p>M. interjectum</p></td><td><p>1 (0.3)</p></td><td/><td/><td/><td><p>1(0.2)</p></td></tr><tr><td><p>M. simiae</p></td><td><p>1 (0.3)</p></td><td char="(" align="char"><p>1(2.0)</p></td><td/><td/><td><p>2 (0.4)</p></td></tr><tr><td><p>M. triplex</p></td><td><p>1 (0.3)</p></td><td/><td/><td/><td><p>1(0.2)</p></td></tr><tr><td><p>M. genavense</p></td><td/><td/><td/><td><p>1 (11.1)</p></td><td><p>1(0.2)</p></td></tr><tr><td><p>M. haemophilum</p></td><td/><td char="(" align="char"><p>10 (20)</p></td><td char="(" align="char"><p>2 (4.1)</p></td><td/><td><p>12 (2.6)</p></td></tr><tr><td><p>M. marinum</p></td><td/><td char="(" align="char"><p>3 (6.0)</p></td><td/><td/><td><p>3 (0.6)</p></td></tr><tr><td><p>M. neoaurum</p></td><td/><td/><td char="(" align="char"><p>2 (4.1)</p></td><td/><td><p>2 (0.4)</p></td></tr><tr><td><p>M. terrae complex</p></td><td/><td char="(" align="char"><p>1 (2.0)</p></td><td/><td/><td><p>1(0.2)</p></td></tr></tbody></table><table-wrap-foot><p>Note: the data was presented as number (%) otherwise specified</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Baseline characteristics of the patients with pulmonary NTM disease (<italic>N</italic> = 352)</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Characteristics</p></th><th><p>No. of subjects (%)</p></th></tr></thead><tbody><tr><td><p>Male, No. (%)</p></td><td><p>182 (51.7)</p></td></tr><tr><td><p>Median Age (IQR) (years)</p></td><td><p>67 (58–74)</p></td></tr><tr><td><p>Median BMI (IQR)</p></td><td><p>18.8 (16.2–21.5)</p></td></tr><tr><td colspan="2"><p>Ethnic groups</p></td></tr><tr><td><p> Chinese</p></td><td><p>306 (86.9)</p></td></tr><tr><td><p> Malay</p></td><td><p>19 (5.4)</p></td></tr><tr><td><p> Indian</p></td><td><p>11 (3.1)</p></td></tr><tr><td><p> Others</p></td><td><p>16 (4.5)</p></td></tr><tr><td colspan="2"><p>Coexisting illness</p></td></tr><tr><td><p> Transplant</p></td><td><p>7 (2.0)</p></td></tr><tr><td><p> HIV</p></td><td><p>13 (3.7)</p></td></tr><tr><td><p> Ischemia heart disease</p></td><td><p>42 (11.9)</p></td></tr><tr><td><p> Congestive heart failure</p></td><td><p>7 (2.0)</p></td></tr><tr><td><p> Malignant diseases</p></td><td><p>96 (27.3)</p></td></tr><tr><td><p> Renal disease</p></td><td><p>11 (3.1)</p></td></tr><tr><td><p> Liver disease</p></td><td><p>9 (2.6)</p></td></tr><tr><td><p> Diabetes mellitus</p></td><td><p>43 (12.2)</p></td></tr><tr><td><p> Cardiovascular disease</p></td><td><p>42 (11.9)</p></td></tr><tr><td><p> COPD</p></td><td><p>46 (13.1)</p></td></tr><tr><td><p> Bronchiectasis</p></td><td><p>128 (36.4)</p></td></tr><tr><td><p> Asthma history</p></td><td><p>14 (4.0)</p></td></tr><tr><td><p> TB history</p></td><td><p>97 (27.6)</p></td></tr><tr><td><p> Cerebrovascular disease</p></td><td><p>14 (4.0)</p></td></tr><tr><td colspan="2"><p>Clinical presentations</p></td></tr><tr><td><p> Cough</p></td><td><p>261 (74.1)</p></td></tr><tr><td><p> Recurrent cough with phlegm production</p></td><td><p>160 (45.5)</p></td></tr><tr><td><p> Haemoptysis</p></td><td><p>114 (32.4)</p></td></tr><tr><td><p> Weight loss</p></td><td><p>28 (8.0)</p></td></tr><tr><td><p> Night sweat</p></td><td><p>7 (2.0)</p></td></tr><tr><td><p> Laboratory Investigations</p></td><td><p>28 (8.0)</p></td></tr><tr><td><p> AFB smear (+)</p></td><td><p>113 (32.1)</p></td></tr><tr><td><p> Blood culture (+)</p></td><td><p>3 (0.9)</p></td></tr><tr><td><p> Sputum culture (+)</p></td><td><p>30 (8.5)</p></td></tr><tr><td colspan="2"><p>Radiological findings</p></td></tr><tr><td colspan="2"><p>Chest X-ray (<italic>N</italic> = 330)</p></td></tr><tr><td><p> Fibrocavitary</p></td><td><p>25 (7.6)</p></td></tr><tr><td><p> Nodular bronchiectasis</p></td><td><p>144 (43.6)</p></td></tr><tr><td colspan="2"><p>CT scan (<italic>N</italic> = 260)</p></td></tr><tr><td><p> Fibrocavitary</p></td><td><p>27 (10.4)</p></td></tr><tr><td><p> Nodular bronchiectasis</p></td><td><p>255 (98.1)</p></td></tr></tbody></table><table-wrap-foot><p>Note: the data was presented as number (%) otherwise specified;</p><p><italic>BMI</italic> body mass index, <italic>COPD</italic> Chronic pulmonary obstructive disease, <italic>TB</italic> tuberculosis, <italic>HIV</italic> Human immunodeficiency virus</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>NTM pulmonary diseases</title><sec id="Sec10"><title>Demographic information and clinical features</title><p id="Par33">Of the 744 patients with NTM isolates from respiratory specimens, 352 patients (47.3%) met ATS/IDSA case criteria for pulmonary NTM disease. <italic>M. abscessus</italic>-<italic>chelonae</italic> group (197, 56%) was the predominately pathogenic species. The median age of the patients was 67 years (Table <xref rid="Tab4" ref-type="table">4</xref>). Malignant diseases, COPD and bronchiectasis were the major comorbidities. Male patients were older, and more often had COPD; whereas female patients more often had bronchiectasis (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>Comparison between male and female patients with NTM lung disease (<italic>N</italic> = 352)</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Characteristics</p></th><th><p>Male (<italic>N</italic> = 182)</p></th><th><p>Female (<italic>N</italic> = 170)</p></th><th><p><italic>P</italic> value</p></th></tr></thead><tbody><tr><td><p>Median Age (25 th-75th IQR) (years)</p></td><td><p>68.5 (61–76)</p></td><td><p>66 (56–73)</p></td><td><p>0.014*</p></td></tr><tr><td><p>Median BMI (25th–75th IQR)</p></td><td><p>18.9 (16.2–22.3)</p></td><td><p>18.6 (16.1–21.3)</p></td><td><p>0.711</p></td></tr><tr><td colspan="4"><p>Coexisting illnesses No. (%)</p></td></tr><tr><td><p> HIV</p></td><td><p>11 (6.0)</p></td><td><p>2 (1.2)</p></td><td><p>0.021*</p></td></tr><tr><td><p> Ischemia heart disease</p></td><td><p>34 (18.7)</p></td><td><p>8 (4.7)</p></td><td><p>&lt; 0.001*</p></td></tr><tr><td><p> Neoplastic disease</p></td><td><p>48 (26.4)</p></td><td><p>48 (28.2)</p></td><td><p>0.7</p></td></tr><tr><td><p> Diabetes mellitus</p></td><td><p>29 (15.9)</p></td><td><p>14 (8.2)</p></td><td><p>0.028*</p></td></tr><tr><td><p> COPD</p></td><td><p>43 (23.6)</p></td><td><p>3 (1.8)</p></td><td><p>&lt; 0.001*</p></td></tr><tr><td><p> Bronchiectasis</p></td><td><p>43 (23.6)</p></td><td><p>85 (50.0)</p></td><td><p>&lt; 0.001*</p></td></tr><tr><td><p> TB history</p></td><td><p>64 (35.2)</p></td><td><p>33 (19.7)</p></td><td><p>0.001*</p></td></tr><tr><td colspan="4"><p>Clinical symptoms</p></td></tr><tr><td><p> Cough</p></td><td><p>141 (77.5)</p></td><td><p>120 (70.6)</p></td><td><p>0.14</p></td></tr><tr><td><p> Recurrent cough with phlegm</p></td><td><p>94 (51.6)</p></td><td><p>66 (38.8)</p></td><td><p>0.035*</p></td></tr><tr><td><p> Haemoptysis</p></td><td><p>50 (27.5)</p></td><td><p>64 (37.6)</p></td><td><p>0.042*</p></td></tr><tr><td><p> Weight loss</p></td><td><p>38 (20.9)</p></td><td><p>33 (19.4)</p></td><td><p>0.73</p></td></tr><tr><td><p> Chest pain</p></td><td><p>17 (9.3)</p></td><td><p>11(6.5)</p></td><td><p>0.33</p></td></tr><tr><td colspan="4"><p>Investigations</p></td></tr><tr><td><p> Median albumin (25th–75th IQR)</p></td><td><p>32 (27–37.2)</p></td><td><p>34 (28–40)</p></td><td><p>0.076</p></td></tr></tbody></table><table-wrap-foot><p>Note: the data was presented as number (%) otherwise specified. Univariate analysis was performed to assess the difference in observed variables between male and female patients with NTM diseases. Categorical variables were tested by Chi-square test or Fisher’s exact test if the frequencies were less than 5*. Continuous variables were examined using non-parametric Mann-Whitney test</p><p><italic>BMI</italic> body mass index,<italic>COPD</italic> chronic pulmonary obstructive disease,<italic>TB</italic> tuberculosis,<italic>HIV</italic> human immunodeficiency virus</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec11"><title>Factors associated with multiple NTM species detection</title><p id="Par34">Of the 352 patients with pulmonary NTM infection, 106 patients had ≥2 NTM species isolated either in the same setting (41/106) or at different time point (65/106). There were no species matching-pattern or sequential order observed. However, univariate analysis revealed that age ≥ 65 years and COPD were associated with multiple NTM species isolation with OR of 1.7 and 2.2 respectively (Table <xref rid="Tab6" ref-type="table">6</xref>).<table-wrap id="Tab6"><label>Table 6</label><caption xml:lang="en"><p>Comparison of NTM lung disease characteristics between patients with 1 NTM species detected and patients with more than 1 NTM species detected</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Characteristics</p></th><th><p>1 species (<italic>N</italic> = 246)</p></th><th><p>≥ 2 species (<italic>N</italic> = 106)</p></th><th><p><italic>P</italic> value</p></th><th><p>OR (95% CI)</p></th></tr></thead><tbody><tr><td><p>Male (%)</p></td><td><p>123 (50)</p></td><td><p>59 (55.7)</p></td><td><p>0.33</p></td><td/></tr><tr><td><p>Age ≥ 65 years</p></td><td><p>136 (55.3)</p></td><td><p>72 (67.9)</p></td><td><p>0.027*</p></td><td char="(" align="char"><p>1.7 (1.1–2.8)</p></td></tr><tr><td><p>Median BMI</p><p>(25th–75th IQR)</p></td><td><p>19.1 (16.4–21.7)</p></td><td><p>18.1 (15.3–21.4)</p></td><td><p>0.14</p></td><td/></tr><tr><td colspan="5"><p>Coexisting illnesses No. (%)</p></td></tr><tr><td><p> HIV</p></td><td><p>11 (4.5)</p></td><td><p>2 (1.9)</p></td><td><p>0.36</p></td><td/></tr><tr><td><p> IHD</p></td><td><p>28 (11.4)</p></td><td><p>14 (13.2)</p></td><td><p>0.63</p></td><td/></tr><tr><td><p> Neoplastic disease</p></td><td><p>73 (29.7)</p></td><td><p>23 (21.7)</p></td><td><p>0.12</p></td><td/></tr><tr><td><p> Diabetes mellitus</p></td><td><p>28 (11.4)</p></td><td><p>15 (14.2)</p></td><td><p>0.47</p></td><td/></tr><tr><td><p> COPD</p></td><td><p>25 (10.2)</p></td><td><p>21 (19.8)</p></td><td><p>0.013*</p></td><td char="(" align="char"><p>2.2 (1.2–4.1)</p></td></tr><tr><td><p> Bronchiectasis</p></td><td><p>87 (35.4)</p></td><td><p>41 (38.7)</p></td><td><p>0.55</p></td><td/></tr><tr><td><p> TB history</p></td><td><p>67 (27.2)</p></td><td><p>30 (28.3)</p></td><td><p>0.84</p></td><td/></tr><tr><td colspan="5"><p>Clinical symptoms No. (%)</p></td></tr><tr><td><p> Cough</p></td><td><p>181 (73.6)</p></td><td><p>80 (75.5)</p></td><td><p>0.71</p></td><td/></tr><tr><td><p> Phlegm</p></td><td><p>110 (44.7)</p></td><td><p>51 (48.1)</p></td><td><p>0.56</p></td><td/></tr><tr><td><p> Haemoptysis</p></td><td><p>76 (30.9)</p></td><td><p>38 (35.8)</p></td><td><p>0.36</p></td><td/></tr><tr><td><p> Weight loss</p></td><td><p>50 (20.3)</p></td><td><p>21 (19.8)</p></td><td><p>0.91</p></td><td/></tr><tr><td><p> Chest pain</p></td><td><p>21 (8.6)</p></td><td><p>7 (6.6)</p></td><td><p>0.53</p></td><td/></tr></tbody></table><table-wrap-foot><p>Note: The data was presented as number (%) unless otherwise specified. Univariate analysis was performed to assess the difference in observed variables between male and female patients with NTM diseases</p><p><italic>BMI</italic> body mass index,<italic>COPD</italic> chronic pulmonary obstructive disease,<italic>TB</italic> tuberculosis,<italic>HIV</italic> human immunodeficiency virus</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec12" sec-type="discussion"><title>Discussion</title><p id="Par35">In this study, we evaluated the clinical relevance of all NTM isolates cultured in CTBL in SGH from 2011 to 2015. We found that 54.6% of the patients with NTM isolates met ATS/IDSA diagnostic criteria of NTM diseases. Nearly half of the patients with pulmonary isolates may have active NTM lung infections, significantly higher than the rates reported in Hong Kong and Korea (47% vs. 20–25%) [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. This may suggest that pulmonary NTM isolates were more likely associated with pulmonary NTM infection rather than colonization among the patients in Singapore.</p><p id="Par36">The distribution of NTM species varies geographically. <italic>M. avium</italic> complex (MAC) are the most commonly isolated and involved in pulmonary NTM infections in the US, Canada, Japan, Korea, Hong Kong and Taiwan [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR40">40</xref>]. In contrast, our study showed that <italic>M. abscessus</italic>-<italic>chelonae</italic> group was the most prevalent and most implicated in pulmonary NTM disease among the patients in Singapore. Here we grouped <italic>M. chelonae</italic> and <italic>M. abscessus</italic> together as the two species could not be reliably differentiated by the line-probe assay (INNO-LiPA). However, an in-house review of isolates that were tested by both INNO-LiPA and HPLC revealed that all <italic>M. abscessus</italic>-<italic>chelonae</italic> group identified by INNO-LiPA were confirmed to be <italic>M. abscessus</italic> by HPLC method (Data not published). In view of this and the fact that <italic>M.</italic> c<italic>helonae</italic> rarely causes chronic lung disease [<xref ref-type="bibr" rid="CR32">32</xref>], <italic>M. abscessus</italic> was likely to be the main pathogenic species in pulmonary NTM infections in our patient cohort. This observation was in line with another study in Singapore and a study conducted in southernmost region of Japan with subtropical climate [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. We postulated the higher prevalence of <italic>M. abscessus</italic> in our setting may be due to the tropical climate, densely populated urban living and history of TB infection. However, more studies are required to prove these hypotheses.</p><p id="Par37"><italic>M. abscessues</italic> subsp<italic>. abscessus</italic> is often associated with poor clinical prognosis because of the possession of a functional <italic>erm</italic> [<xref ref-type="bibr" rid="CR41">41</xref>] gene that confers macrolide resistance. <italic>M. abscessus</italic> subsp. <italic>massiliense</italic>, on the other hand, generally remains susceptible to macrolide due to the truncation of <italic>erm</italic> gene [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Subspeciation of <italic>M. abscessus</italic> complex may provide important guidance in the clinical management of <italic>M. abscessus</italic> complex infection. Unfortunately, this data is not available during the study period as the test was not performed routinely<italic>.</italic> In addition, macrolide resistance is not routinely tested. If clinically indicated, the clinicians will order susceptibility testing for <italic>M abscessus</italic> and the microbroth dilution plate will be kept for a total of 14 days to detect inducible macrolide resistance. This is in accordance to CLSI (Clinical and Laboratory Standards Institute) M24-A2 [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p id="Par38">In this study<italic>, M. fortuitum species group</italic> was detected in about 25% of the patients with pulmonary NTM diseases. The role of <italic>M. fortuitum</italic> group as the causative agent in infection can be controversial because it could be colonization or transient infection [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. However, some studies have reported that <italic>M. fortuitum</italic> is the pathogen implicated in pulmonary NTM infection and skin and bone/joint infection as well [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR50">50</xref>]. Therefore, it should always be correlated with the clinical findings to determine its clinical significance and management. In addition, <italic>M. kansasii is</italic> a virulent but an uncommon species in Asia. However, it was surprisingly the fourth commonest NTM species implicated in pulmonary infection among the patients in Singapore [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Hence, it is important to understand the local epidemiology before applying guidelines elsewhere.</p><p id="Par39">Structural lung diseases predispose people to pulmonary NTM infection [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR56">56</xref>]. In this study, about 50% of patients with pulmonary NTM infection had COPD or bronchiectasis. Male patients had a higher incidence of COPD and more often presented with recurring cough and sputum production; in contrast, female patients had bronchiectasis and haemoptysis more frequently. These distinct features were consistent with the findings observed in other studies [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Pulmonary tuberculosis is another important pathophysiological process associated with severe pulmonary structural damage. A history of tuberculosis is a distinct characteristic among Asian patients with pulmonary NTM diseases [<xref ref-type="bibr" rid="CR59">59</xref>]. In this study, one-third of the patients with pulmonary NTM infections had prior TB, which was not surprising as the incidence of TB in Singapore was about 307 cases per 100,000 population in 1960 [<xref ref-type="bibr" rid="CR28">28</xref>]. By the way, the prevalence of pulmonary NTM disease was similar in male and female patients. Both male and female patients had slim figure with BMI close to the lower end of the normal range (18.9 kg/m<sup>2</sup> and 18.6 kg/m<sup>2</sup> respectively).</p><p id="Par40">Isolation of multiple NTM species in the same setting or over a period of time is another feature of NTM lung infection and the underlying reason is unclear [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. In this study, around 30% of the pulmonary NTM patients had ≥2 species identified. As clinical treatment data was not gathered in current study, we cannot tell if was related to clinical treatment as suggested by Lee et al. [<xref ref-type="bibr" rid="CR63">63</xref>] However, we found that age ≥ 65 years and COPD were significantly associated with multispecies isolation with OR of 1.7 and 2.2 respectively. Chronic inflammation and remodelling of airways in COPD may play a role in the increased susceptibility to NTM infection.</p><p id="Par41">This study has several limitations. Firstly, this is a retrospective study and the collected data may be incomplete. Secondly, the study was conducted in a single hospital not all adult tertiary-care hospitals in Singapore. Nonetheless, as patients from all over Singapore can seek care from any tertiary-care hospital in the country, any selection bias was likely to be minimal. Thirdly, there may be an underestimation in the prevalence of pulmonary NTM infections as approximately half of the cases with single NTM isolate from sputum or had no characteristic radiological findings were excluded from the analysis based on ATS/IDSA guideline.</p></sec><sec id="Sec13" sec-type="conclusions"><title>Conclusions</title><p id="Par42">About half of the patients in Singapore with NTM isolates met ATS/IDAS criteria of NTM diseases with highest prevalence of pulmonary NTM disease. Of the 16 NTM species (group) detected in this study, <italic>M. abscessus-chelonae group</italic> was the most frequently isolated and most involved in pulmonary NTM diseases. The patients with pulmonary NTM disease were characterized with advanced age, having history of TB and other chronic illnesses such as malignant diseases and structural lung diseases. Male patients were more associated with COPD, whereas female patients more often had bronchiectasis. Increasing age and COPD were associated with multiple NTM species detection per patient.</p></sec></body><back><ack><title>Acknowledgements</title><sec><p>The authors are thankful for senior statistician Joshua Wong’s help in data analysis.</p></sec><sec id="FPar2"><title>Funding</title><p id="Par44">This study was not funded.</p></sec><sec id="FPar3"><title>Availability of data and materials</title><p id="Par45">The summary data supporting the manuscript are included within the article. The raw data are not available due to Singapore Personal Data Protection Act (PDPA). We need to seek the approval of our institution (Singapore General Hospital) to release the raw data should there be a request from the public.</p></sec></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>ZZ, TYE and SLH contributed to the design of the project. TYE and SLH performed laboratory data extraction and set up patient cohort. ZZ and BC conducted clinical data extraction and data analysis. All authors read and approved the final manuscript. The first author ZZ was a former employee of Singapore General Hospital during the study period.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethical approval</title><p id="Par43">Ethical approval and waiver of informed consent was approved by the Centralized Institutional Review Boards of SingHealth Authority of Singapore (2015/2020).</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par46">Not applicable.</p></sec><sec id="FPar5" sec-type="COI-statement"><title>Competing interests</title><p id="Par47">All authors declared no competing interest associated with this study.</p></sec><sec id="FPar6"><title>Publisher’s Note</title><p id="Par48">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MM</given-names></name><name><surname>Odell</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Nontuberculous mycobacterial pulmonary infections</article-title><source>J Thorac Dis</source><year>2014</year><volume>6</volume><issue>3</issue><fpage>210</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">24624285</pub-id><pub-id pub-id-type="pmcid">3949190</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fordham von Reyn</surname><given-names>C</given-names></name><name><surname>Arbeit</surname><given-names>RD</given-names></name><name><surname>Tosteson</surname><given-names>AN</given-names></name><name><surname>Ristola</surname><given-names>MA</given-names></name><name><surname>Barber</surname><given-names>TW</given-names></name><name><surname>Waddell</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">The international epidemiology of disseminated <italic>Mycobacterium avium</italic> complex infection in AIDS. International MAC Study Group</article-title><source>Aids</source><year>1996</year><volume>10</volume><issue>9</issue><fpage>1025</fpage><lpage>1032</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2s%2Fgs1Cntg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1097/00002030-199610090-00014</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Reyn</surname><given-names>CF</given-names></name><name><surname>Waddell</surname><given-names>RD</given-names></name><name><surname>Eaton</surname><given-names>T</given-names></name><name><surname>Arbeit</surname><given-names>RD</given-names></name><name><surname>Maslow</surname><given-names>JN</given-names></name><name><surname>Barber</surname><given-names>TW</given-names></name><etal/></person-group><article-title xml:lang="en">Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya</article-title><source>J Clin Microbiol</source><year>1993</year><volume>31</volume><issue>12</issue><fpage>3227</fpage><lpage>3230</lpage></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaerewijck</surname><given-names>MJ</given-names></name><name><surname>Huys</surname><given-names>G</given-names></name><name><surname>Palomino</surname><given-names>JC</given-names></name><name><surname>Swings</surname><given-names>J</given-names></name><name><surname>Portaels</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Mycobacteria in drinking water distribution systems: ecology and significance for human health</article-title><source>FEMS Microbiol Rev</source><year>2005</year><volume>29</volume><issue>5</issue><fpage>911</fpage><lpage>934</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtFSisLnN</pub-id><pub-id pub-id-type="doi">10.1016/j.femsre.2005.02.001</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriguchi</surname><given-names>S</given-names></name><name><surname>Kita</surname><given-names>S</given-names></name><name><surname>Yabuki</surname><given-names>Y</given-names></name><name><surname>Inagaki</surname><given-names>R</given-names></name><name><surname>Izumi</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Reduced CaM kinase II and CaM kinase IV activities underlie cognitive deficits in NCKX2 heterozygous mice</article-title><source>Mol Neurobiol</source><year>2018</year><volume>55</volume><issue>5</issue><fpage>3889</fpage><lpage>3900</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXos1Sks7o%3D</pub-id><pub-id pub-id-type="pmid">28547530</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>ED</given-names></name><name><surname>Iseman</surname><given-names>MD</given-names></name></person-group><article-title xml:lang="en">Underlying host risk factors for nontuberculous mycobacterial lung disease</article-title><source>Semin Respir Crit Care Med</source><year>2013</year><volume>34</volume><issue>1</issue><fpage>110</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1333573</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winthrop</surname><given-names>KL</given-names></name><name><surname>Baxter</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Varley</surname><given-names>CD</given-names></name><name><surname>Curtis</surname><given-names>JR</given-names></name><name><surname>Baddley</surname><given-names>JW</given-names></name><etal/></person-group><article-title xml:lang="en">Mycobacterial diseases and antitumour necrosis factor therapy in USA</article-title><source>Ann Rheum Dis</source><year>2013</year><volume>72</volume><issue>1</issue><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXitFaqs7c%3D</pub-id><pub-id pub-id-type="doi">10.1136/annrheumdis-2011-200690</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brode</surname><given-names>SK</given-names></name><name><surname>Jamieson</surname><given-names>FB</given-names></name><name><surname>Ng</surname><given-names>R</given-names></name><name><surname>Campitelli</surname><given-names>MA</given-names></name><name><surname>Kwong</surname><given-names>JC</given-names></name><name><surname>Paterson</surname><given-names>JM</given-names></name><etal/></person-group><article-title xml:lang="en">Increased risk of mycobacterial infections associated with anti-rheumatic medications</article-title><source>Thorax</source><year>2015</year><volume>70</volume><issue>7</issue><fpage>677</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2014-206470</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrejak</surname><given-names>C</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name><name><surname>Thomsen</surname><given-names>VO</given-names></name><name><surname>Duhaut</surname><given-names>P</given-names></name><name><surname>Sorensen</surname><given-names>HT</given-names></name><name><surname>Thomsen</surname><given-names>RW</given-names></name></person-group><article-title xml:lang="en">Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis</article-title><source>Thorax</source><year>2013</year><volume>68</volume><issue>3</issue><fpage>256</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2012-201772</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>WJ</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Suh</surname><given-names>GY</given-names></name><name><surname>Chung</surname><given-names>MP</given-names></name><etal/></person-group><article-title xml:lang="en">Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease</article-title><source>Chest</source><year>2007</year><volume>131</volume><issue>6</issue><fpage>1825</fpage><lpage>1830</lpage><pub-id pub-id-type="doi">10.1378/chest.06-2280</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>ED</given-names></name><name><surname>Iseman</surname><given-names>MD</given-names></name></person-group><article-title xml:lang="en">Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease</article-title><source>Gend Med</source><year>2010</year><volume>7</volume><issue>1</issue><fpage>5</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.genm.2010.01.005</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winthrop</surname><given-names>KL</given-names></name><name><surname>Varley</surname><given-names>CD</given-names></name><name><surname>Ory</surname><given-names>J</given-names></name><name><surname>Cassidy</surname><given-names>PM</given-names></name><name><surname>Hedberg</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA</article-title><source>Emerg Infect Dis</source><year>2011</year><volume>17</volume><issue>9</issue><fpage>1760</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.3201/eid1709.101929</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falkinham</surname><given-names>JO</given-names><suffix>3rd</suffix></name></person-group><article-title xml:lang="en">Ecology of nontuberculous mycobacteria--where do human infections come from?</article-title><source>Semin Respir Crit Care Med</source><year>2013</year><volume>34</volume><issue>1</issue><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1333568</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adjemian</surname><given-names>J</given-names></name><name><surname>Olivier</surname><given-names>KN</given-names></name><name><surname>Seitz</surname><given-names>AE</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Prevots</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>185</volume><issue>8</issue><fpage>881</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1164/rccm.201111-2016OC</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156(2 Pt 2):S1–25.</mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax. 2000;55(3):210–8.</mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prevots</surname><given-names>DR</given-names></name><name><surname>Shaw</surname><given-names>PA</given-names></name><name><surname>Strickland</surname><given-names>D</given-names></name><name><surname>Jackson</surname><given-names>LA</given-names></name><name><surname>Raebel</surname><given-names>MA</given-names></name><name><surname>Blosky</surname><given-names>MA</given-names></name><etal/></person-group><article-title xml:lang="en">Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><issue>7</issue><fpage>970</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1164/rccm.201002-0310OC</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strollo</surname><given-names>SE</given-names></name><name><surname>Adjemian</surname><given-names>J</given-names></name><name><surname>Adjemian</surname><given-names>MK</given-names></name><name><surname>Prevots</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">The burden of pulmonary nontuberculous mycobacterial disease in the United States</article-title><source>Ann Am Thorac Soc</source><year>2015</year><volume>12</volume><issue>10</issue><fpage>1458</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.201503-173OC</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marras</surname><given-names>TK</given-names></name><name><surname>Mendelson</surname><given-names>D</given-names></name><name><surname>Marchand-Austin</surname><given-names>A</given-names></name><name><surname>May</surname><given-names>K</given-names></name><name><surname>Jamieson</surname><given-names>FB</given-names></name></person-group><article-title xml:lang="en">Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><issue>11</issue><fpage>1889</fpage><lpage>1891</lpage><pub-id pub-id-type="doi">10.3201/eid1911.130737</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>WJ</given-names></name><name><surname>Kwon</surname><given-names>OJ</given-names></name><name><surname>Jeon</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><etal/></person-group><article-title xml:lang="en">Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea</article-title><source>Chest</source><year>2006</year><volume>129</volume><issue>2</issue><fpage>341</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1378/chest.129.2.341</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okumura</surname><given-names>M</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><name><surname>Ogata</surname><given-names>H</given-names></name><name><surname>Ueyama</surname><given-names>M</given-names></name><name><surname>Kubota</surname><given-names>M</given-names></name><name><surname>Aoki</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease</article-title><source>Intern Med</source><year>2008</year><volume>47</volume><issue>16</issue><fpage>1465</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.47.1114</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>CC</given-names></name><name><surname>Tan</surname><given-names>CK</given-names></name><name><surname>Chou</surname><given-names>CH</given-names></name><name><surname>Hsu</surname><given-names>HL</given-names></name><name><surname>Liao</surname><given-names>CH</given-names></name><name><surname>Huang</surname><given-names>YT</given-names></name><etal/></person-group><article-title xml:lang="en">Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008</article-title><source>Emerg Infect Dis</source><year>2010</year><volume>16</volume><issue>2</issue><fpage>294</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.3201/eid1602.090675</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>CL</given-names></name></person-group><article-title xml:lang="en">Recovery rates of non-tuberculous mycobacteria from clinical specimens are increasing in Korean tertiary-care hospitals</article-title><source>J Korean Med Sci</source><year>2017</year><volume>32</volume><issue>8</issue><fpage>1263</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.3346/jkms.2017.32.8.1263</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kee</surname><given-names>SJ</given-names></name><name><surname>Suh</surname><given-names>SP</given-names></name></person-group><article-title xml:lang="en">Increasing burden of nontuberculous mycobacteria in Korea</article-title><source>J Korean Med Sci</source><year>2017</year><volume>32</volume><issue>8</issue><fpage>1215</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.3346/jkms.2017.32.8.1215</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namkoong</surname><given-names>H</given-names></name><name><surname>Kurashima</surname><given-names>A</given-names></name><name><surname>Morimoto</surname><given-names>K</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>N</given-names></name><name><surname>Ato</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan(1)</article-title><source>Emerg Infect Dis</source><year>2016</year><volume>22</volume><issue>6</issue><fpage>1116</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.3201/eid2206.151086</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>HL</given-names></name><name><surname>Cheng</surname><given-names>MH</given-names></name><name><surname>Lu</surname><given-names>PL</given-names></name><name><surname>Shu</surname><given-names>CC</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><etal/></person-group><article-title xml:lang="en">Epidemiology and predictors of NTM pulmonary infection in Taiwan - a retrospective, Five-Year Multicenter Study</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>16300</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-16559-z</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Population trends. <ext-link xlink:href="https://www.singstat.gov.sg/-/media/files/publications/population/population2017.pdf" ext-link-type="url">https://www.singstat.gov.sg/-/media/files/publications/population/population2017.pdf</ext-link>. Cited 10 Sept 2018.</mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Tuberculosis. <ext-link xlink:href="https://www.moh.gov.sg/diseases-updates/tuberculosis" ext-link-type="url">https://www.moh.gov.sg/diseases-updates/tuberculosis</ext-link>. Cited 10 Sept 2018.</mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Buadu</surname><given-names>EO</given-names></name><name><surname>Stark</surname><given-names>P</given-names></name><name><surname>Sarinas</surname><given-names>PS</given-names></name><name><surname>Chitkara</surname><given-names>RK</given-names></name><name><surname>Kuschner</surname><given-names>WG</given-names></name></person-group><article-title xml:lang="en">Clinical and chest radiographic findings among persons with sputum culture positive for Mycobacterium gordonae: a review of 19 cases</article-title><source>Chest</source><year>2000</year><volume>117</volume><issue>1</issue><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD3c%2FpvVChtw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1378/chest.117.1.96</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolinsky</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Nontuberculous mycobacteria and associated diseases</article-title><source>Am Rev Respir Dis</source><year>1979</year><volume>119</volume><issue>1</issue><fpage>107</fpage><lpage>159</lpage><pub-id pub-id-type="coi">1:STN:280:DyaE1M7it1GgtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">369415</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhri</surname><given-names>S</given-names></name><name><surname>Manfreda</surname><given-names>J</given-names></name><name><surname>Wolfe</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>S</given-names></name><name><surname>Long</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center</article-title><source>Clin Infect Dis</source><year>1995</year><volume>21</volume><issue>1</issue><fpage>128</fpage><lpage>133</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK28%2FmsFKhtw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1093/clinids/21.1.128</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>DE</given-names></name><name><surname>Aksamit</surname><given-names>T</given-names></name><name><surname>Brown-Elliott</surname><given-names>BA</given-names></name><name><surname>Catanzaro</surname><given-names>A</given-names></name><name><surname>Daley</surname><given-names>C</given-names></name><name><surname>Gordin</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>175</volume><issue>4</issue><fpage>367</fpage><lpage>416</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXjtlajsL4%3D</pub-id><pub-id pub-id-type="doi">10.1164/rccm.200604-571ST</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosker</surname><given-names>HS</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name><name><surname>Ng</surname><given-names>TK</given-names></name><name><surname>Ma</surname><given-names>HK</given-names></name><name><surname>Chan</surname><given-names>SL</given-names></name></person-group><article-title xml:lang="en">The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong</article-title><source>Respir Med</source><year>1995</year><volume>89</volume><issue>1</issue><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2M3isVaqtw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/0954-6111(95)90063-2</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winthrop</surname><given-names>KL</given-names></name><name><surname>McNelley</surname><given-names>E</given-names></name><name><surname>Kendall</surname><given-names>B</given-names></name><name><surname>Marshall-Olson</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>C</given-names></name><name><surname>Cassidy</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><issue>7</issue><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1164/rccm.201003-0503OC</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>RJ</given-names></name><name><surname>Geiter</surname><given-names>LJ</given-names></name><name><surname>Snider</surname><given-names>DE</given-names><suffix>Jr</suffix></name></person-group><article-title xml:lang="en">The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey</article-title><source>Am Rev Respir Dis</source><year>1987</year><volume>135</volume><issue>5</issue><fpage>1007</fpage><lpage>1014</lpage><pub-id pub-id-type="coi">1:STN:280:DyaL2s3htFeksg%3D%3D</pub-id><pub-id pub-id-type="pmid">3579001</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>PM</given-names></name><name><surname>Hedberg</surname><given-names>K</given-names></name><name><surname>Saulson</surname><given-names>A</given-names></name><name><surname>McNelly</surname><given-names>E</given-names></name><name><surname>Winthrop</surname><given-names>KL</given-names></name></person-group><article-title xml:lang="en">Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology</article-title><source>Clin Infect Dis</source><year>2009</year><volume>49</volume><issue>12</issue><fpage>e124</fpage><lpage>e129</lpage><pub-id pub-id-type="doi">10.1086/648443</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>DS</given-names></name><name><surname>Peterson</surname><given-names>DD</given-names></name><name><surname>Steiner</surname><given-names>RM</given-names></name><name><surname>Gottlieb</surname><given-names>JE</given-names></name><name><surname>Scott</surname><given-names>R</given-names></name><name><surname>Israel</surname><given-names>HL</given-names></name><etal/></person-group><article-title xml:lang="en">Infection with Mycobacterium avium complex in patients without predisposing conditions</article-title><source>N Engl J Med</source><year>1989</year><volume>321</volume><issue>13</issue><fpage>863</fpage><lpage>868</lpage><pub-id pub-id-type="coi">1:STN:280:DyaL1MzmsFSktg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1056/NEJM198909283211304</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukamura</surname><given-names>M</given-names></name><name><surname>Kita</surname><given-names>N</given-names></name><name><surname>Shimoide</surname><given-names>H</given-names></name><name><surname>Arakawa</surname><given-names>H</given-names></name><name><surname>Kuze</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Studies on the epidemiology of nontuberculous mycobacteriosis in Japan</article-title><source>Am Rev Respir Dis</source><year>1988</year><volume>137</volume><issue>6</issue><fpage>1280</fpage><lpage>1284</lpage><pub-id pub-id-type="coi">1:STN:280:DyaL1M%2FnsFWkug%3D%3D</pub-id><pub-id pub-id-type="doi">10.1164/ajrccm/137.6.1280</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>WJ</given-names></name><name><surname>Kwon</surname><given-names>OJ</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name></person-group><article-title xml:lang="en">Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective</article-title><source>J Korean Med Sci</source><year>2005</year><volume>20</volume><issue>6</issue><fpage>913</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.3346/jkms.2005.20.6.913</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brode</surname><given-names>SK</given-names></name><name><surname>Marchand-Austin</surname><given-names>A</given-names></name><name><surname>Jamieson</surname><given-names>FB</given-names></name><name><surname>Marras</surname><given-names>TK</given-names></name></person-group><article-title xml:lang="en">Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario, Canada</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><issue>11</issue><fpage>1898</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.3201/eid2311.170959</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>AYH</given-names></name><name><surname>Chotirmall</surname><given-names>SH</given-names></name><name><surname>Fok</surname><given-names>ETK</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>De</surname><given-names>PP</given-names></name><name><surname>Goh</surname><given-names>SK</given-names></name><etal/></person-group><article-title xml:lang="en">Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore</article-title><source>BMC Pulm Med</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s12890-018-0637-1</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname><given-names>H</given-names></name><name><surname>Kinjo</surname><given-names>T</given-names></name><name><surname>Nei</surname><given-names>Y</given-names></name><name><surname>Yamashiro</surname><given-names>S</given-names></name><name><surname>Fujita</surname><given-names>J</given-names></name><name><surname>Kishaba</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Causative species of nontuberculous mycobacterial lung disease and comparative investigation on clinical features of Mycobacterium abscessus complex disease: a retrospective analysis for two major hospitals in a subtropical region of Japan</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>10</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0186826</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name><name><surname>Dukart</surname><given-names>G</given-names></name><name><surname>Brown-Elliott</surname><given-names>BA</given-names></name><name><surname>Griffith</surname><given-names>DE</given-names></name><name><surname>Scerpella</surname><given-names>EG</given-names></name><name><surname>Marshall</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections</article-title><source>J Antimicrob Chemother</source><year>2014</year><volume>69</volume><issue>7</issue><fpage>1945</fpage><lpage>1953</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtVWms7%2FJ</pub-id><pub-id pub-id-type="doi">10.1093/jac/dku062</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MR</given-names></name><name><surname>Sheng</surname><given-names>WH</given-names></name><name><surname>Hung</surname><given-names>CC</given-names></name><name><surname>Yu</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>LN</given-names></name><name><surname>Hsueh</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Mycobacterium abscessus complex infections in humans</article-title><source>Emerg Infect Dis</source><year>2015</year><volume>21</volume><issue>9</issue><fpage>1638</fpage><lpage>1646</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XitVOisbrF</pub-id><pub-id pub-id-type="doi">10.3201/2109.141634</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>GL</given-names></name><name><surname>Brown-Elliott</surname><given-names>B</given-names></name><name><surname>Desmond</surname><given-names>E</given-names></name><name><surname>Hall</surname><given-names>GS</given-names></name><name><surname>Heifets</surname><given-names>L</given-names></name><name><surname>Pfyffer</surname><given-names>GE</given-names></name><etal/></person-group><source>Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes</source><year>2003</year><fpage>18</fpage><lpage>23</lpage></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Suh</surname><given-names>GY</given-names></name><name><surname>Chung</surname><given-names>MP</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>OJ</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><etal/></person-group><article-title xml:lang="en">Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens</article-title><source>Respir Med</source><year>2008</year><volume>102</volume><issue>3</issue><fpage>437</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2007.10.005</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Charles</surname><given-names>L</given-names></name><name><surname>Daley</surname><given-names>DEG</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Nadel's</surname><given-names>M</given-names></name></person-group><source>Nontuberculous Mycobacterial Infections</source><year>2016</year><edition>6</edition></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamori</surname><given-names>S</given-names></name><name><surname>Asakura</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Tamizu</surname><given-names>E</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Natural history of Mycobacterium fortuitum pulmonary infection presenting with migratory infiltrates: a case report with microbiological analysis</article-title><source>BMC Infect Dis</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/s12879-017-2892-9</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lessing</surname><given-names>MP</given-names></name><name><surname>Walker</surname><given-names>MM</given-names></name></person-group><article-title xml:lang="en">Fatal pulmonary infection due to Mycobacterium fortuitum</article-title><source>J Clin Pathol</source><year>1993</year><volume>46</volume><issue>3</issue><fpage>271</fpage><lpage>272</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK3s3hs12muw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1136/jcp.46.3.271</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agheli</surname><given-names>A</given-names></name><name><surname>Tehranirad</surname><given-names>M</given-names></name><name><surname>Cofsky</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">An unusual presentation of mycobacterium fortuitum: massive isolated empyema in a patient with HIV</article-title><source>MedGenMed</source><year>2006</year><volume>8</volume><issue>2</issue><fpage>90</fpage><pub-id pub-id-type="pmid">16926829</pub-id><pub-id pub-id-type="pmcid">1785183</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hojo</surname><given-names>M</given-names></name><name><surname>Iikura</surname><given-names>M</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Sugiyama</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>N</given-names></name><name><surname>Kudo</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy</article-title><source>Respirology.</source><year>2012</year><volume>17</volume><issue>1</issue><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1843.2011.02076.x</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritscher</surname><given-names>LG</given-names></name><name><surname>Marras</surname><given-names>TK</given-names></name><name><surname>Bradi</surname><given-names>AC</given-names></name><name><surname>Fritscher</surname><given-names>CC</given-names></name><name><surname>Balter</surname><given-names>MS</given-names></name><name><surname>Chapman</surname><given-names>KR</given-names></name></person-group><article-title xml:lang="en">Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study</article-title><source>Chest</source><year>2011</year><volume>139</volume><issue>1</issue><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1378/chest.10-0186</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Char</surname><given-names>A</given-names></name><name><surname>Hopkinson</surname><given-names>NS</given-names></name><name><surname>Hansell</surname><given-names>DM</given-names></name><name><surname>Nicholson</surname><given-names>AG</given-names></name><name><surname>Shaw</surname><given-names>EC</given-names></name><name><surname>Clark</surname><given-names>SJ</given-names></name><etal/></person-group><article-title xml:lang="en">Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study</article-title><source>BMC Pulm Med</source><year>2014</year><volume>14</volume><fpage>124</fpage><pub-id pub-id-type="doi">10.1186/1471-2466-14-124</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>E</given-names></name><name><surname>Amitani</surname><given-names>R</given-names></name><name><surname>Niimi</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Murayama</surname><given-names>T</given-names></name><name><surname>Kuze</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><year>1997</year><volume>155</volume><issue>6</issue><fpage>2041</fpage><lpage>2046</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2szjvFGitg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1164/ajrccm.155.6.9196113</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>J</given-names></name><name><surname>Aliberti</surname><given-names>S</given-names></name><name><surname>Mirsaeidi</surname><given-names>M</given-names></name><name><surname>Peyrani</surname><given-names>P</given-names></name><name><surname>Filardo</surname><given-names>G</given-names></name><name><surname>Amir</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Acute myocardial infarction in hospitalized patients with community-acquired pneumonia</article-title><source>Clin Infect Dis</source><year>2008</year><volume>47</volume><issue>2</issue><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1086/589246</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiz</surname><given-names>L</given-names></name><name><surname>Giron</surname><given-names>R</given-names></name><name><surname>Olveira</surname><given-names>C</given-names></name><name><surname>Vendrell</surname><given-names>M</given-names></name><name><surname>Nieto</surname><given-names>R</given-names></name><name><surname>Martinez-Garcia</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study</article-title><source>BMC Infect Dis</source><year>2016</year><volume>16</volume><issue>1</issue><fpage>437</fpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC2szjtlyhtg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1186/s12879-016-1774-x</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>VO</given-names></name><name><surname>Andersen</surname><given-names>AB</given-names></name><name><surname>Miorner</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey</article-title><source>Scand J Infect Dis</source><year>2002</year><volume>34</volume><issue>9</issue><fpage>648</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1080/00365540210147813</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ingen</surname><given-names>J</given-names></name><name><surname>Bendien</surname><given-names>SA</given-names></name><name><surname>de Lange</surname><given-names>WC</given-names></name><name><surname>Hoefsloot</surname><given-names>W</given-names></name><name><surname>Dekhuijzen</surname><given-names>PN</given-names></name><name><surname>Boeree</surname><given-names>MJ</given-names></name><etal/></person-group><article-title xml:lang="en">Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands</article-title><source>Thorax</source><year>2009</year><volume>64</volume><issue>6</issue><fpage>502</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1136/thx.2008.110957</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>S</given-names></name><name><surname>van Ingen</surname><given-names>J</given-names></name><name><surname>Hsueh</surname><given-names>PR</given-names></name><name><surname>Van Hung</surname><given-names>N</given-names></name><name><surname>Dekhuijzen</surname><given-names>PN</given-names></name><name><surname>Boeree</surname><given-names>MJ</given-names></name><etal/></person-group><article-title xml:lang="en">Nontuberculous mycobacteria in respiratory tract infections, eastern Asia</article-title><source>Emerg Infect Dis</source><year>2011</year><volume>17</volume><issue>3</issue><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.3201/eid170310060</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>DE</given-names></name><name><surname>Girard</surname><given-names>WM</given-names></name><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name></person-group><article-title xml:lang="en">Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients</article-title><source>Am Rev Respir Dis</source><year>1993</year><volume>147</volume><issue>5</issue><fpage>1271</fpage><lpage>1278</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK3s3kvFajsw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1164/ajrccm/147.5.1271</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>CM</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Yang</surname><given-names>SC</given-names></name><etal/></person-group><article-title xml:lang="en">Isolation of multiple nontuberculous mycobacteria species in the same patients</article-title><source>Int J Infect Dis</source><year>2011</year><volume>15</volume><issue>11</issue><fpage>e795</fpage><lpage>e798</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2011.07.004</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Brown</surname><given-names>BA</given-names></name><name><surname>Dawson</surname><given-names>D</given-names></name><name><surname>Murphy</surname><given-names>DT</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>158</volume><issue>4</issue><fpage>1235</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.158.4.9712098</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Yoon</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Seong</surname><given-names>MW</given-names></name><name><surname>Han</surname><given-names>SK</given-names></name><etal/></person-group><article-title xml:lang="en">Implication of species change of nontuberculous mycobacteria during or after treatment</article-title><source>BMC Pulm Med</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>213</fpage><pub-id pub-id-type="doi">10.1186/s12890-017-0539-7</pub-id></mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>AFB</term><def><p id="Par5">Acid- Fast Bacilli</p></def></def-item><def-item><term>ATS/IDSA</term><def><p id="Par6">American Thoracic Society/Infectious Disease Society of America</p></def></def-item><def-item><term>BAL</term><def><p id="Par7">Bronchoalveolar lavage</p></def></def-item><def-item><term>BMI</term><def><p id="Par8">Body-mass index</p></def></def-item><def-item><term>CI</term><def><p id="Par9">Confidence interval</p></def></def-item><def-item><term>COPD</term><def><p id="Par10">Chronic obstructive pulmonary disease</p></def></def-item><def-item><term>CTBL</term><def><p id="Par11">Central Tuberculosis Laboratory</p></def></def-item><def-item><term>CXR</term><def><p id="Par12">Chest X-ray</p></def></def-item><def-item><term>DM</term><def><p id="Par13">Diabetes mellitus</p></def></def-item><def-item><term>ETTA</term><def><p id="Par14">Endotracheal tube aspirate</p></def></def-item><def-item><term>HRCT</term><def><p id="Par15">High resolution computed tomography</p></def></def-item><def-item><term>IHD</term><def><p id="Par16">Ischemic heart disease</p></def></def-item><def-item><term>IQR</term><def><p id="Par17">Interquartile range</p></def></def-item><def-item><term>MAC</term><def><p id="Par18"><italic>M. avium</italic> complex</p></def></def-item><def-item><term>NTM</term><def><p id="Par19">Non-tuberculous mycobacteria</p></def></def-item><def-item><term>OR</term><def><p id="Par20">Odds ratio</p></def></def-item><def-item><term>SGH</term><def><p id="Par21">Singapore General Hospital</p></def></def-item><def-item><term>TB</term><def><p id="Par22">Tuberculosis</p></def></def-item><def-item><term>TNFα</term><def><p id="Par23">Tumour necrosis factor alpha</p></def></def-item></def-list></glossary></back></article></records><facets><facet name="subject"><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Internal Medicine</facet-value><facet-value count="1">Medical Microbiology</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Parasitology</facet-value><facet-value count="1">Tropical Medicine</facet-value></facet><facet name="keyword"><facet-value count="1">
                Mycobacterium abscessus
              </facet-value><facet-value count="1">Non-tuberculous mycobacteria</facet-value><facet-value count="1">Singapore</facet-value></facet><facet name="pub"><facet-value count="1">BMC Infectious Diseases</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Singapore</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
